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of pulmonary cryptococcosis results in increased
IL-17A production by gamma/delta T cells
Karen L Wozniak1,2, Jay K Kolls3 and Floyd L Wormley Jr1,2*Abstract
Protective responses in mice immunized with an interferon-gamma producing strain of Cryptococcus neoformans,
H99γ, are associated with IL-17A production by neutrophils. Neutrophil depletion in H99γ-immunized mice did not
affect pulmonary fungal burden, indicating that neutrophils are not required for clearance. However, we observed
an increase in IL-17A in the lungs of neutrophil-depleted H99γ infected mice, which corresponded to an increase in
IL-17A+ γδ+ T cells. Moreover, we observed increased IL-17A+/ CD3+ cells and IL-17A+/γδ+ cells, but decreased
IL-17A+/Ly6G+ neutrophils in the lungs of IL-17 receptor (R)A deficient mice compared to wild-type mice. Increased
production of IL-17A in neutropenic mice coincided with increased IL-6 and CXCL1, but not Th17 inducing
cytokines TGF-β, IL-21 and IL-23. Concurrent depletion of neutrophils and γδ+ T cells reduced IL-17A levels. Our
results suggest that γδ+ T cells mediate significant IL-17A production in neutropenic mice during the protective
response to C. neoformans infection.
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Cryptococcus neoformans is an opportunistic fungal patho-
gen that primarily affects patients with impaired T cell-
mediated immunity. Clinically, symptomatic cryptococcal
infections have been observed in individuals with AIDS,
solid-organ transplant recipients receiving immunosup-
pressive medicines to prevent organ rejection, and
patients taking chemotherapeutic drugs [1-5]. Experi-
mental studies in mice have suggested that protection
against cryptococcosis is primarily associated with the
induction of Th1-type anti-cryptococcal cell-mediated
immune responses [6-13]. In addition, Th17-type immune
responses have been shown to be important for protection
against multiple fungal pathogens [14-18]. However, the
specific function of IL-17A and/or Th17-type immune
responses in mediating protection against cryptococcal in-
fection is uncertain [19-23].* Correspondence: floyd.wormley@utsa.edu
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reproduction in any medium, provided the orPreviously, we have shown that mice immunized with
an interferon-gamma (IFN-γ) producing strain of Cryp-
tococcus neoformans, denoted H99γ, were completely
protected against subsequent challenge with wild-type
cryptococci [11,12]. Protection was associated with the
induction of Th1-type and pro-inflammatory cytokine
responses and IL-17A production early during infection
in protected animals [11,12]. While protection against C.
neoformans strain H99γ required intact Th1-type cyto-
kine responses, mice depleted of IL-17A and IL-17 re-
ceptor (R) A deficient (IL-17RA−/−) mice were able to
survive acute infection with C. neoformans strain H99γ
and no evidence of H99γ dissemination to the brain was
observed [24]. Furthermore, IL-17RA−/− mice immu-
nized with C. neoformans strain H99γ were able to re-
solve a subsequent pulmonary challenge with wild-type
C. neoformans strain H99. Nonetheless, some surviving
IL-17RA−/− mice exhibited evidence of dissemination of
C. neoformans to the brain that was not observed in
their immune competent counterparts, suggesting that
prevention of dissemination is an important protective
feature of IL-17A during cryptococcosis [24]. Our prior
studies using intracellular cytokine staining followed byl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ducers of IL-17A in our model system were neutrophils
rather than Th17-type CD4+ T cells [24]. Furthermore,
the IL-17A produced in our model of cryptococcal infec-
tion was not proceeded or accompanied by the produc-
tion of cytokines that typically initiate Th17-type
responses (i.e., TGF-β, IL-21, or IL-23) [12]. This is not
unique, as other investigators have observed IL-17A pro-
duction by neutrophils in other model systems [25-27].
Also, IL-17A production by multiple cell types including
CD8+ T cells, γδ+ T cells, NK cells, and NKT cells have
been demonstrated [25,28-37]. In the current studies, we
further explored the role of neutrophils and IL-17A pro-
duction in mice during infection with C. neoformans
strain H99γ. Interestingly, depletion of neutrophils in
mice infected with C. neoformans strain H99γ resulted
in a significant increase of IL-17A in lung homogenates,
which necessitated a search for alternate sources of IL-
17A in neutropenic mice. The eventual depletion of neu-
trophils in combination with other cell types led to the
identification of γδ+ T cells as a source of IL-17A pro-
duction during pulmonary infection with C. neoformans
strain H99γ.
Results
Depletion of neutrophils in mice infected with C.
neoformans strain H99γ leads to increased IL-17A in lung
homogenates
Our previous work employing intracellular cytokine
staining followed by flow cytometric analysis suggested
that neutrophils were the primary leukocyte source of
IL-17A in mice infected with C. neoformans strain H99γ
[24]. Therefore, we sought to determine the effect of
neutrophil depletion on IL-17A production in the lungs
of mice during infection with C. neoformans strain
H99γ. Mice were depleted of neutrophils using two dif-
ferent neutrophil depletion antibodies, the anti-Gr1 anti-
body (clone RB6-8C5) and the anti-Ly6G antibody
(clone 1A8), and control animals were treated with iso-
type control antibody beginning 24 hours prior to infec-
tion and every 48 hours thereafter. Total leukocytes
were isolated from lung digests on day 7 post-infection
to confirm neutrophil depletion and to phenotype
the local leukocyte population. This time point was
chosen because it is the time point at which pulmonary
IL-17A production is at its peak during infection with
C. neoformans strain H99γ [24]. Additionally, protein
homogenates were prepared from lung tissues on day 7
post-infection to evaluate pulmonary IL-17A cytokine
production and fungal burden in neutrophil depleted
mice compared to isotype control antibody treated ani-
mals. Each depletion protocol implemented resulted in a
successful depletion of both the absolute cell numbers
and percentage of neutrophils present in the lungscompared to isotype control antibody treated mice
(Figure 1A and B). Following neutrophil depletion with
either antibody, fungal burden was not significantly
different compared to that observed in isotype control
antibody treated animals at day 7 post-inoculation
(Figure 1C and D), as observed by previous investigators
[38]. Interestingly, pulmonary homogenates of mice
depleted of neutrophils by either antibody had signifi-
cantly higher IL-17A present compared to mice treated
with isotype control antibody (Figure 1E and F). While
this result seemed counterintuitive, it is not unique and
has been observed in other model systems during neu-
trophil depletion [26,39]. Previous studies have sug-
gested that IL-10 production by neutrophils may lead to
an inhibition of IL-17A production in the lungs [40].
However, we observed no significant difference in IL-10
present within lung homogenates derived from isotype
control antibody treated mice in comparison to that
observed in neutrophil depleted mice on day 7 post-
inoculation (11.64 pg/ml ± 1.36 and 12.58 pg/ml ± 0.94,
in isotype control antibody treated and clone 1A8 trea-
ted mice, respectively). Due to its cross-reactivity to the
Ly6C antigen, the anti-Gr1 antibody depleted not only
neutrophils but also CD8+ T cells (data not shown), as
seen in studies by other investigators [41]. In contrast,
the 1A8 clone was observed to specifically deplete neu-
trophils. Other leukocyte populations examined follow-
ing 1A8 neutrophil depletion (CD4+ T cells, CD8+ T
cells, macrophages, dendritic cells, regulatory T cells,
natural killer T cells, γδ+ T cells, natural killer cells, eosi-
nophils, and B cells) were not affected (data not shown).
Therefore, we elected to perform all further experiments
using the 1A8 antibody for neutrophil depletion.
Determination of IL-17A-producing population in the
absence of neutrophils
We sought to determine the population responsible for
the increased production of IL-17A in the lungs of neu-
trophil depleted mice on day 7 post-infection with C.
neoformans strain H99γ. Total leukocytes were isolated
from lung tissues, and the leukocyte subpopulations
were characterized for intracellular IL-17A expression
by flow cytometry. Leukocyte populations examined
included neutrophils, CD4+ T cells, CD8+ T cells, macro-
phages, dendritic cells, regulatory T cells, natural killer T
cells, natural killer cells, γδ+ T cells, B cells, and eosino-
phils. Figure 2 demonstrates that the only cell type with
increased intracellular IL-17A expression during neutro-
phil depletion was the γδ+ T cell population. As
expected, the percentage of IL-17A+ neutrophils was sig-
nificantly reduced in neutrophil depleted mice, and
other leukocyte subsets including CD4+ T cells and den-
dritic cells had significantly reduced intracellular staining
for IL-17A following neutrophil depletion (Figure 2).
Figure 1 Neutrophil depletion does not influence fungal burden but is associated with increased pulmonary levels of IL-17A during
infection with C. neoformans strain H99γ. BALB/c mice received an intranasal inoculum of 1 × 104 CFU of C. neoformans strain H99γ in 50 μl of
sterile PBS. Prior to and during infection, mice were treated with isotype control antibody (white bars) or with either anti-1A8 antibody or
anti-Gr1 antibody (gray bars). Lungs were excised at day 7 post-inoculation, and neutrophil depletion, absolute numbers and percentages (A, B),
pulmonary cryptococcal burden (C, D) and IL-17A production (E, F) quantified. Asterisks (*) indicate where significant differences (P < 0.05) were
observed in neutrophil depleted mice compared to isotype-control treated mice following infection with C. neoformans strain H99γ. Fungal
burden results are expressed as mean CFU per milliliter ± standard errors of the means. Data are cumulative of four experiments using
4 mice per group.
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depleted mice
In order to confirm our observation that γδ+ T cells had
increased IL-17A production in mice depleted of neutro-
phils, we isolated γδ+ T cells from H99γ-infected mice
treated with either isotype control antibody or the 1A8
neutrophil-depleting antibody on day 7 post-infection.Once isolated, γδ+ T cells were plated in tissue culture
wells with and without cryptococcal antigen for 24 h.
Following incubation, supernatants were harvested and
examined for IL-17A by ELISA, and cells were examined
for intracellular IL-17A by flow cytometry. Results
showed that IL-17A protein levels (Figure 3A) as well as
intracellular IL-17A (Figure 3B) were significantly
Figure 2 Lung γδ+ T cells are the predominant leukocyte population expressing IL-17A during pulmonary infection with C. neoformans
strain H99γ during neutrophil depletion. BALB/c mice received an intranasal inoculum of 1 × 104 CFU of C. neoformans strain H99γ in 50 μl of
sterile PBS. Mice were treated with isotype control antibody (white bars) or with anti-1A8 antibody (gray bars). The lungs were excised at day 7
post-inoculation and a single cell suspension generated using enzymatic digestion. The leukocytes were stained with anti-mouse antibodies
(CD45, 1A8 (Neut), CD4, CD8, F4/80 (Mac), CD11b/CD11c (DC), CD4/Fox3p (Treg), CD3/NKp46 (NKT), NKp46/CD45 (NK), γδ/CD45 (γδ+ T cells),
CD19 (B cell), SiglecF/CD11b (Eosinophil), fixed, permeabilized, and incubated with anti-IL-17A antibodies and evaluated by flow cytometry. Flow
cytometry data are cumulative results of three independent experiments using pooled leukocytes from 4 mice per group per experiment. Results
shown are the percentage of leukocytes expressing the indicated surface markers and IL-17A. Asterisks (*) indicate where significant differences
(P < 0.05) were observed between isotype control-treated and anti-1A8-treated mice infected with C. neoformans strain H99γ.
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compared to isotype control-treated mice, therefore con-
firming our previous observations (Figure 2).
Cytokine production and intracellular IL-17A expression
in mice deficient in IL-17RA signaling
We hypothesized that intracellular staining for IL-17A
may be indicative of which cells produce IL-17A;
therefore, we wanted to rule out the possibility that our
intracellular staining may be detecting the recipients of
IL-17A. Consequently, we evaluated IL-17A production
in IL-17RA−/− mice compared to wild-type mice on day
7 following infection with C. neoformans strain H99γ.
We rationalized that increased cellular production of IL-Figure 3 Ex-vivo IL-17A production from γδ+ T cells following neutro
CFU of C. neoformans strain H99γ in 50 μl of sterile PBS. Mice were treated
were excised at day 7 post-inoculation and a single cell suspension genera
further purified for γδ+ T cells. The γδ+ T cells were plated at 1 × 105 cells/w
bars) or with C. neoformans cell wall extract (CWE) (gray bars). Cell superna
indicate where significant differences (P < 0.05) were observed between γδ
those from mice treated with the 1A8 neutrophil depletion antibody. Data17A will be observed but IL-17A uptake will not be
detected in IL-17RA−/− mice, thus providing some
insight into which cells are the producers and/or the tar-
get for IL-17A in our model system. We observed a sig-
nificant increase in IL-17A within lung homogenates
derived from IL-17RA−/− mice compared to wild-type
mice on day 7 post-infection with C. neoformans strain
H99γ (Figure 4A). Total leukocytes were also isolated
from lung tissues, and the leukocyte subpopulations
characterized for intracellular IL-17A expression by flow
cytometry. We observed an overall decrease, though not
reaching statistical significance, in the percentage of IL-
17A+ neutrophils in IL-17RA−/− mice compared to wild-
type mice. However, significantly increased IL-17A+/CD3+phil depletion. BALB/c mice received an intranasal inoculum of 1x104
with isotype control antibody or with anti-1A8 antibody. The lungs
ted using enzymatic digestion. The leukocytes were isolated and then
ell and incubated for 24 h at 37°C, 5% CO2 with media alone (white
tants were removed and examined for IL-17A by ELISA. Asterisks (*)
+ T cells from mice treated with isotype control antibody compared to
are cumulative of three separate experiments.
Figure 4 Induction of IL-17A production during C. neoformans strain H99γ infection requires signaling through the IL-17A receptor.
BALB/c (white bars) and IL-17RA KO (gray bars) mice were given an intranasal inoculation with C. neoformans strain H99γ. Lungs were excised at
day 7 post-inoculation, and pulmonary cytokine production quantified (A) and intracellular IL-17A production was determined in leukocyte
populations (B). The lungs were excised at day 7 post-inoculation and a single cell suspension generated using enzymatic digestion. The
leukocytes were stained with anti-mouse antibodies (CD45, 1A8 (Neut), CD4, CD8, F4/80 (Mac), CD11b/CD11c (DC), CD4/Fox3p (Treg), CD3/NKp46
(NKT), NKp46/CD45 (NK), γδ/CD45 (γδ+ T cells), CD19 (B cell), SiglecF/CD11b (Eosinophil), fixed, permeabilized, and incubated with anti-mouse
antibodies specific for IL-17A and quantified by flow cytometry. Asterisks (*) indicate where significant differences (P < 0.05) were observed
between WT and IL-17RA KO mice infected with C. neoformans strain H99γ. Data are cumulative of three experiments using 3 mice per group.
Figure 5 Neutrophil depletion during pulmonary infection with C. neoformans strain H99γ results in significant production of neutrophil
chemoattractant cytokines, but little change in Th17-type cytokine production in the lungs. BALB/c mice were given an intranasal
inoculation with C. neoformans strain H99γ. Mice were treated with isotype control antibody (white bars) or with anti-1A8 antibody (gray bars). Lung
homogenates were prepared from lungs excised on day 7 post-inoculation and assayed for IL-6, G-CSF, CXCL1, TGF-β, IL-21, and IL-23 cytokine production.
Data are cumulative of three experiments using 5 mice each per group. Asterisks (*) indicate where significant differences (P< 0.05) were observed.
Wozniak et al. BMC Immunology 2012, 13:65 Page 5 of 11
http://www.biomedcentral.com/1471-2172/13/65
Figure 6 Neutrophil and γδ+ T cell depletion does not affect
fungal burden, but does abrogate IL-17A production in mice
infected with C. neoformans strain H99γ. BALB/c mice received
an intranasal inoculum of 1 × 104 CFU of C. neoformans strain H99γ
in 50 μl of sterile PBS. Prior to and during infection, mice were
treated with isotype control antibody (white bars) or with anti-1A8
antibody (gray bars), anti-1A8/CD4 (checkered bars), anti-1A8/CD8
(slashed bars), anti-1A8/CD4/CD8 (striped bars), and anti-1A8/γδ (thin
slashed bars). Lungs were excised at day 7 post-inoculation, and IL-
17A (A) and pulmonary cryptococcal burden (B) quantified. Asterisks
(*) indicate where significant increases in depleted mice compared
to isotype-control treated mice (P < 0.05), tau (τ) indicates significant
decreases in depleted mice compared to neutrophil (1A8) depleted
mice (P < 0.05) following infection with C. neoformans strain H99γ.
Fungal burden results are expressed as mean CFU per milliliter ±
standard errors of the mean (SEM), and IL-17A results are expressed
as the mean pg/ml ± SEM. Data are cumulative of three experiments
using 4 mice per group.
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the lungs of IL-17RA−/− mice compared to wild-type mice
on day 7 post-infection (Figure 4B). No other significant
differences were observed.
Cytokine and chemokine production in mice depleted of
neutrophils
We posited that other cytokines/chemokines known to
induce neutrophil chemotaxis may be increased in the
lungs of neutrophil depleted mice following infection
with H99γ, since recruitment of neutrophils occurs dur-
ing infection with H99γ. Therefore, we determined the
expression of cytokines involved in neutrophil recruit-
ment, including IL-6, G-CSF, and CXCL1, within
the lungs of neutrophil depleted and isotype control
antibody treated mice on day 7 post-infection with
C. neoformans strain H99γ. As shown in Figure 5A, IL-
6, G-CSF, and CXCL1 were significantly increased in the
lung homogenates of neutrophil depleted mice com-
pared to lung homogenates of isotype control antibody
treated mice, suggesting an attempt by the host to re-
cruit neutrophils to the site of infection. Cytokines typic-
ally associated with a Th17-type response, IL-21, IL-23,
and TGF-β, were also investigated to support our previ-
ous observation that the IL-17A response to this infec-
tion is part of an overall chemokine response and not
associated with a classical Th17-type response. IL-21
and IL-23 levels were not significantly changed during
neutrophil depletion, and TGF-β was significantly
decreased in neutrophil depleted mice in comparison to
isotype control antibody treated mice (Figure 5B).
Depletion of additional leukocyte populations during
neutrophil depletion
Our observation that CD3+ and γδ+ cells have signifi-
cantly increased intracellular IL-17A production during
neutrophil depletion led us to examine these populations
more closely. For this, mice were depleted of neutrophils
alone, or neutrophils in combination with CD4+ T cells
and/or CD8+ T cells, and γδ+ T cells and given an ex-
perimental pulmonary infection with C. neoformans
strain H99γ. IL-17A production and pulmonary fungal
burden was subsequently analyzed on day 7 post-
inoculation. Depletion of neutrophils in combination
with CD4+ and/or CD8+ T cell subsets did not affect IL-
17A production in the lungs of infected mice compared
to infected mice treated with isotype control antibody
(Figure 6A). In contrast, depletion of neutrophils in
combination with γδ+ T cells resulted in a significant re-
duction in pulmonary IL-17A compared to IL-17A
detected in lung homogenates of mice depleted of neu-
trophils alone on day 7 post-infection (Figure 5A).
Nonetheless, we observed no significant difference in
pulmonary fungal burden in all depletion groups at day7 post-infection (Figure 6B). Therefore, the γδ+ T cells
appear to be responsible for the increased IL-17A
detected in lung homogenates of neutropenic mice
infected with C. neoformans strain H99γ.Discussion
Our results discussed herein show that γδ+ T cells pro-
duce significant quantities of IL-17A in mice depleted of
neutrophils during pulmonary infection with C. neofor-
mans strain H99γ. The production of IL-17A did not ap-
pear commensurate with the percentage of IL-17A+ γδ+
T cells observed in pulmonary tissues of C. neoformans
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of neutrophils and γδ+ T cells resulted in a significant
reduction in pulmonary IL-17A production compared to
mice depleted of neutrophils alone. This may suggest
that neutrophils negatively regulate the production of
IL-17A from γδ+ T cells. Previous studies have suggested
that IL-10 production by neutrophils may lead to an in-
hibition of IL-17A production in the lungs [40], however,
we observed no evidence of this occurring in our model
system. Alternatively, the presence of cytokines or other
stimulants that promote IL-17A production by γδ+ T
cells may be enhanced in the lungs of neutrophil
depleted mice in our model system. Thus, neutrophils
would only indirectly influence IL-17A production by
γδ+ T cells. While we are uncertain of the mechanism,
we are not the first to demonstrate a contribution by
γδ+ T cells to IL-17A production [27,29-31,34,35], and
these data provide us with additional insight into per-
haps an underappreciated role of γδ+ T cells in cytokine
production at the pulmonary mucosa. In our model of
protection against pulmonary cryptococcosis using C.
neoformans strain H99γ, IL-17A production appears to
work in concert with Th1-type immune responses to
mediate protection and prevent dissemination to the
brain [11,12]. Previous experiments employing intracel-
lular staining for IL-17A followed by flow cytometric
analysis indicated neutrophils as the predominant source
of IL-17A in the lung during protective anti-
cryptococcal immune responses [24]. Neutrophils do not
appear to be critical for clearance of pulmonary C. neo-
formans infections; indeed, depletion of neutrophils
alone in mice was shown to prolong survival and lower
fungal burden [38]. However, neutrophils are phagocytic,
anti-fungal, and also participate in the production of
cytokines that enhance protective anti-cryptococcal im-
mune responses [41-44]. Quite possibly, other cell types
assume a greater effector role against C. neoformans to
compensate for the absence of neutrophils in the lung.
The γδ+ T cell is an often overlooked cell type in im-
munity, but recent reports indicate that these cells pro-
vide critical protection in response to a variety of
infections [39,45]. Their role in protection and IL-17A
production has also recently been shown in several dif-
ferent models [28,35,36], thus supporting these current
findings. While these cells were originally thought to be
a primordial innate T cell with no memory capabilities
(reviewed in [46]), more recent studies have shown that
γδ+ T cells actually can respond to pathogen challenge
and may function as a bridge between innate and adap-
tive immune responses [45]. Recent studies with the fun-
gal organism Candida albicans have shown that IL-17A
production by γδ+ T cells is important in early protec-
tion [39]. However, a previous study examining γδ KO
mice as well as depletion of γδ+ T cells duringcryptococcal infection showed enhanced fungal clear-
ance [39]. In our model, which uses a different strain of
mice and Cryptococcus, however, depletion of γδ+ T cells
did not affect pulmonary fungal burden at early time
points. Future studies in our laboratory will address the
role of γδ+ T cells in mediating long-term protection
during acute infection with our protective H99γ strain
and subsequent survival following challenge with wild-
type C. neoformans strain H99.
We previously showed that immunization with C. neo-
formans strain H99γ induced protection against a subse-
quent intranasal challenge with wild-type C. neoformans
strain H99 in mice depleted of CD4+ T cells and/or CD8+
T cells [47]. Clinically, we know that C. neoformans infec-
tion results in significant morbidity and mortality in
immune compromised individuals with low CD4+ T
cells [1-5]. Traditional “innate” cell populations, such as
NK cells, NKT cells, LTi cells, and γδ+ T cells can medi-
ate protective immunity in the presence or absence of
traditional adaptive mechanisms [48-52]. Demonstrating
that cell populations such as γδ+ T cells participate in
protective anti-cryptococcal immune responses and
uncovering a means to enhance these responses will be
critical to the development of effective immune therapies
and/or vaccines targeted for use in immunocompromised
patient populations.
In these data presented herein, we used intracellular
cytokine staining followed by flow cytometry analysis to
determine the IL-17A-producing population of cells
within mice given an experimental pulmonary infection
with C. neoformans strain H99γ. However, we acknow-
ledge that this technique may not adequately represent
the entire picture since intracellular staining only allows
us to identify the percentage of positively-stained cells,
and therefore it is not quantitative. Therefore, it is pos-
sible that we may be underestimating the contributions
of specific leukocyte populations as producers of IL-
17A, since we cannot determine the specific amount of
IL-17A produced by each individual cell type using
intracellular staining alone. Also, intracellular staining
may identify cells that are the target cells for the
cytokine, in addition to cells producing the cytokine.
Further, our ex vivo data using purified γδ+ T cells from
H99γ-infected mice depleted of neutrophils verified their
IL-17A production. Our results using mice deficient in
IL-17RA signaling show that the percentage of IL-17A+
neutrophils were decreased by approximately 47% com-
pared to wild-type mice during infection with C. neofor-
mans strain H99γ, which supports this conclusion. In
addition to γδ+ T cells, other CD3+ cells can also pro-
duce IL-17A, including invariant natural killer cells
(iNK) and lymphoid tissue inducer cells (LTi) [53-55].
However, we examined these cell types and did not ob-
serve the presence of these cells in the lung during
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Wormley, unpublished observations).
Conclusions
In conclusion, the data presented herein describe the
identification of the γδ+ T cell as a significant source of
IL-17A in the lungs of neutropenic mice during infec-
tion with C. neoformans strain H99γ. Depletion of these
cells leads to abrogation of the enhanced IL-17A pro-
duction observed upon depletion of neutrophils during
infection with the protective C. neoformans strain H99γ.
These γδ+ T cells may play an important role in
leukocyte chemotaxis and the induction of protective
immune responses to C. neoformans, especially in the
absence of traditional adaptive immune responses. If this
proves to be the case, these findings may have implica-
tions in the design of treatments or vaccines to combat
cryptococcal disease. Ongoing studies are examining the
role of these cells during challenge with wild-type C.
neoformans strain H99, and their potential role in ani-
mals lacking all traditional adaptive immune cell types.
Methods
Mice
Female BALB/c (H-2d) (National Cancer Institute/
Charles River Laboratories, Boston, MA and The Jack-
son Laboratory, Bar Harbor, ME) and IL-17 receptor A
knock out (IL-17RA−/−) mice (a kind gift of Amgen, Inc.
Thousand Oaks, CA), all on the BALB/c background
with an average weight of 20–25 grams, were used
throughout these studies. This study was carried out in
strict accordance with the recommendations in the
Guide for the Care and Use of Laboratory Animals of
the National Institutes of Health. Mice were housed at
The University of Texas at San Antonio Small Animal
Laboratory Vivarium. These animal experiments were
approved by The University of Texas at San Antonio In-
stitutional Animal Care and Use Committee (IACUC),
and mice were handled according to IACUC guidelines.
All efforts were made to minimize animal suffering.
Strains and media
C. neoformans strain H99γ (serotype A, Mat α, an
interferon-gamma producing strain derived from C. neo-
formans H99 [11]) was recovered from 15% glycerol
stocks stored at −80°C prior to use in the experi-
ments described herein. The strain was maintained on
yeast-extract-peptone-dextrose (YPD) media (1% yeast
extract, 2% peptone, 2% dextrose, and 2% Bacto agar) sup-
plemented with nourseothricin. Yeast cells were grown
for 18–20 h at 30°C with shaking in YPD broth (Becton
Dickinson and Company, Sparks, MD), collected by
centrifugation, washed three times with sterile phosphate-
buffered saline (PBS), and viable yeast quantified usingtrypan blue dye exclusion in a hemacytometer. For tissue
culture, complete medium consisted of RPMI 1640
supplemented with 10% heat-inactivated fetal bovine
serum, 2 mM L-glutamine, 100 U penicillin/ml, 100 μg of
streptomycin/ml, and 50 mM 2-mercaptoethanol.
Pulmonary infections
Pulmonary C. neoformans infections were initiated by
nasal inhalation as previously described [12]. BALB/c
mice were anesthetized with 2% isoflurane using a ro-
dent anesthesia device (Eagle Eye Anesthesia, Jackson-
ville, FL) and then given a yeast inoculum of 1 × 104
colony forming units (CFU) of C. neoformans strain
H99γ in 50 μl of sterile PBS pipetted directly into the
nares. The inocula used were verified by quantitative
culture on YPD agar. The mice were fed ad libitum and
were monitored by inspection twice daily. Mice were
euthanized at specific time points post-inoculation by
CO2 inhalation followed by cervical dislocation, and lung
tissues were excised using aseptic technique. Tissues
were homogenized in 1 ml of sterile PBS, followed by
culture of 10-fold dilutions of each tissue on YPD agar
supplemented with chloramphenicol (Mediatech, Inc.,
Herndon, VA). CFU were enumerated following incuba-
tion at 30°C for 48 h.
Pulmonary leukocyte isolation
Lungs were excised at specific time points post-
inoculation and digested enzymatically at 37°C for
30 minutes in 10 ml of digestion buffer (RPMI 1640 and
1 mg/ml of collagenase type IV [Sigma-Aldrich, St.
Louis, MO.]) with intermittent (every 10 min) stomacher
homogenizations. The enzymatically-digested tissues
were then successively filtered through sterile nylon fil-
ters of various pore sizes (70 and 40 μm) (BD Bios-
ciences) and washed with sterile HBSS to enrich for
leukocytes. Erythrocytes were lysed by incubation in
NH4Cl buffer (0.859% NH4Cl, 0.1% KHCO3, 0.0372%
Na2EDTA [pH 7.4]; Sigma-Aldrich) for 3 minutes on ice
followed by the addition of a 10-fold excess of PBS. The
resulting leukocyte population was then collected by
centrifugation (800 × g) for 5 minutes, washed
twice with sterile PBS, resuspended in sterile PBS + 2%
heat-inactivated fetal bovine serum (FACS buffer) and
enumerated in a hemacytometer using trypan blue dye
exclusion. Flow cytometric analysis was used to deter-
mine the percentage of each leukocyte population as
well as the absolute number of total leukocytes (CD45+)
within the lung cell suspension for standardization of
hemacytometer counts.
Cell depletions
For neutrophil depletion experiments, mice received ei-
ther 200 μg anti-Gr1 antibody (clone RB6-8C5) (BioXCell)
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volume of 100 μl injected intraperitoneally beginning
24 hours post-inoculation and continuing every other
day throughout the study. For depletion of gamma-delta
T cells, mice received 100 μg anti-gamma-delta T cell re-
ceptor antibody (eBioscience) via the intraperitoneal
route beginning two days prior to inoculation and con-
tinued weekly throughout the experiment. These con-
centrations and schedules were chosen following studies
testing different dosages and schedules in our laboratory
to determine the optimum dosage and schedule for each
antibody (data not shown). Controls for neutrophil and
γδ+ T cell depletions included mice treated with IgG2a
isotype control antibody (eBioscience Inc., San Diego,
CA) via the intraperitoneal route. Mice were depleted
of CD4+ and/or CD8+ T cell subsets via intraperitoneal
administration of anti-CD4 (GK1.5, rat IgG2b) and anti-
CD8α (2.43, rat IgG2b) antibodies (each from National
Cell Culture Center, Minneapolis, MN). Each mouse
received 200 μg of GK1.5 and/or 2.43 or control rat
IgG2b (eBioscience Inc.) antibodies in a volume of 100 μl
PBS 48 h prior to infection and weekly thereafter. Cellu-
lar depletions were confirmed for each experiment by
flow cytometry using antibodies that adhere to epitopes
distinct from those adhered to by the depletion anti-
bodies. Antibodies depleted approximately 95% of neu-
trophils, 98% of γδ+ T cells, 98% of CD4+ T cells, and
98% of CD8+ T cells (data not shown).
Antibodies
For flow cytometry experiments, cells were incubated
with CD16/CD32 (Fc Block™) (BD Biosciences, San
Diego, CA) and the following antibodies conjugated to
phycoerythrin (PE), allophycocyanin (APC), Alexa 647,
or PECy7 were added: a cocktail of CD3, CD4, and
CD8α; CD45, CD19, Siglec-F (BD Biosciences), 1A8,
CD11c, CD11b, F4/80, NKp46, Fox3P, γδ, IL-17A,
FcεR1α, CD117, CD34 (eBioscience Inc.), and F4/80
(Caltag Laoratories, Burlingame, CA).
Flow cytometry
Standard methodology was employed for the direct im-
munofluorescence of pulmonary leukocytes. Briefly, in 96-
well U-bottom plates, 100 μl containing 1 × 106 cells in
PBS + 2% FBS (FACS buffer) were incubated with 50 μl of
Fc Block™ (BD Biosciences) diluted in FACS buffer for
5 minutes to block non-specific binding of antibodies to
cellular Fc receptors. Subsequently, an optimal concentra-
tion of fluorochrome-conjugated antibodies (between
0.06-0.5 μg/1 × 106 cells in 50 μl of FACS buffer) were
added in various combinations to allow for dual or triple
staining experiments, and plates were incubated for
30 minutes at 4°C. Following incubation, the cells were
washed three times with FACS buffer and cells were fixedin 200 μl of 2% ultrapure formaldehyde (Polysciences, Inc.,
Warrington, PA) diluted in FACS buffer (fixation buffer).
For intracellular staining, cells remained in fixation buffer
for 10 min at room temperature. After fixation, the cells
were washed and permeabilized with 0.1% saponin for
10 min at room temperature. While permeabilized, the cells
were intracellularly stained with anti-IL-17A (eBioscience
Inc.) and/or anti-Fox3P (regulatory T cell) (eBioscience
Inc.) for 30 min at 4°C. Cells were then washed 3 times with
0.1% saponin and then resuspended in fixation buffer before
flow cytometry was performed. Cells incubated with either
FACS buffer alone or single fluorochrome-conjugated
antibodies were used to determine positive staining
and spillover/compensation calculations and the flow cyt-
ometer determined background fluorescence. The samples
were analyzed using BD FACSArray softwareTM on a BD
FACSArray flow cytometer (BD Biosciences). Dead cells
were excluded on the basis of forward angle and 90° light
scatter. For data analyses, 30,000 events (cells) were evalu-
ated from a predominantly leukocytic population identi-
fied by backgating from CD45+-stained cells. The absolute
number of total leukocytes was quantified by multiplying
the total number of cells observed by hemacytometer
counting by the percentage of CD45+ cells determined
by flow cytometry. The absolute number of each
leukocyte subset (1A8, F4/80+, CD11c+/CD11bint,
CD19+, CD4+/CD3+, CD8+/CD3+, CD4+/Fox3p+,
CD3-/NKp46+, CD3+/NKp46+, γδ+, Siglec-F+/CD11bint
was determined by multiplying the percentage of each
gated population by the total number of CD45+ cells.γδ+ T cell ex vivo IL-17 production
Following leukocyte enrichment (see above), lung leuko-
cytes from mice treated with either isotype control anti-
body or with anti-1A8 antibody were enriched for γδ+ T
cells by positive selection using magnetic beads labeled
with γδ antibody according to the manufacturer’s recom-
mendations (Miltenyi Biotec, Auburn, CA). Cells were
counted, and 1 × 105 cells/well were plated in triplicate in
96-well plates, with either complete media alone or with
100 μg/ml C. neoformans cell wall extract (CWE) [13].
CWE was tested for endotoxin contamination before use,
and levels were confirmed to be <1 EU/μg protein (data
not shown). Cells were incubated at 37°C, 5% CO2 for
24 hr. Following incubation, cells were centrifuged and
supernatants were removed for quantification of IL-17A
by ELISA. Remaining cells were harvested and used for
intracellular IL-17A staining by flow cytometry.Cytokine analysis
Cytokine levels in lung tissues were analyzed using the
Bio-Plex Protein Array System (Luminex-based technol-
ogy) (Bio-Rad Laboratories, Hercules, CA). Briefly, lung
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PBS (1 ml). An aliquot (50 μl) was taken to quantify the
pulmonary fungal burden and an anti-protease buffer so-
lution (1 ml) containing PBS, protease inhibitors (inhi-
biting cysteine, serine, and other metalloproteinases) and
0.05% Triton X-100 was added to the homogenate.
Samples were then clarified by centrifugation (800 × g)
for 5 minutes. Supernatants from pulmonary homoge-
nates were assayed using the Bio-Plex Protein Array
System (Bio-Rad Laboratories) for the presence of IL-6,
IL-10, IL-17A, and granulocyte-colony stimulating factor
(G-CSF) expression, as well as the chemokine
keratinocyte-derived chemokine (KC) (CXCL1). ELISA
assays were performed according to manufacturer’s
instructions to measure TGF-β, IL-23 (R&D Systems),
and IL-21 (BD Biosciences) on pulmonary homogenates,
and IL-17A ELISA (R&D Systems) was used to measure
IL-17A in cell culture supernatants.
Statistical analysis
The unpaired Student’s t test (two-tailed) was used to
analyze fungal burden, pulmonary cell populations,
and cytokine/chemokine data using GraphPad Prism
version 5.00 for Windows (GraphPad Prism Software,
San Diego California USA). For multiple comparisons, a
one-way ANOVA with the Tukey’s multiple comparison
test was performed. Significant differences were defined
as P < 0.05.
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